Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice

Obesity triggers a low-grade systemic inflammation, which plays an important role in the development of obesity-associated metabolic diseases. In searching for links between lipid accumulation and chronic inflammation, we examined invariant natural killer T (iNKT) cells, a subset of T lymphocytes th...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 109; no. 19; pp. 7142 - 7143
Main Authors Wu, Lan, Parekh, Vrajesh V., Gabriel, Curtis L., Bracy, Deanna P., Marks-Shulman, Pamela A., Tamboli, Robyn A., Kim, Sungjune, Mendez-Fernandez, Yanice V., Besra, Gurdyal S., Lomenick, Jefferson P., Williams, Brandon, Wasserman, David H., Van Kaer, Luc
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 08.05.2012
National Acad Sciences
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Obesity triggers a low-grade systemic inflammation, which plays an important role in the development of obesity-associated metabolic diseases. In searching for links between lipid accumulation and chronic inflammation, we examined invariant natural killer T (iNKT) cells, a subset of T lymphocytes that react with lipids and regulate inflammatory responses. We show that iNKT cells respond to dietary lipid excess and become activated before or at the time of tissue recruitment of inflammatory leukocytes, and that these cells progressively increase proinflammatory cytokine production in obese mice. Such iNKT cells skew other leukocytes toward proinflammatory cytokine production and induce an imbalanced proinflammatory cytokine environment in multiple tissues. Further, iNKT cell deficiency ameliorates tissue inflammation and provides protection against obesity-induced insulin resistance and hepatic steatosis. Conversely, chronic iNKT cell stimulation using a canonical iNKT cell agonist exacerbates tissue inflammation and obesity-associated metabolic disease. These findings place iNKT cells into the complex network linking lipid excess to inflammation in obesity and suggest new therapeutic avenues for obesity-associated metabolic disorders.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Author contributions: L.W., D.H.W., and L.V.K. designed research; L.W., V.V.P., C.L.G., D.P.B., P.A.M.-S., R.A.T., S.K., Y.V.M.-F., J.P.L., and B.W. performed research; G.S.B. contributed new reagents/analytic tools; L.W., V.V.P., C.L.G., D.H.W., and L.V.K. analyzed data; and L.W., D.H.W., and L.V.K. wrote the paper.
Edited* by Peter Cresswell, Yale University School of Medicine, New Haven, CT, and approved March 19, 2012 (received for review January 10, 2012)
3Present address: Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.
4Present address: Department of Radiation Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL 33612.
1Present address: Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1200498109